@junaidmianrph@LongevityTalk@mfoundation Highly appreciated this long form discussion! I think this is really needed to get to the bone of perceived differences in the field. What really drives aging?
With promising early trials, round table discussions turn to efficacy of different precursors and ethics of placebos in NAD+ trials. @NoAge100@TheFangGroupUiO
Thank you for an insightful review of Lifespan by @davidasinclair . Can't wait to dig into it once it's arrived. Really intriguing bet on the nature of epigenetic reprogramming. I know which part I would take...
@oslobysykkel har dere noen offentlig oversikt over fremtidige planer for stativ? På Løren er det for eksempel storstilt byggeaktivitet og kronisk manko på sykler.
There is a growing number of Norwegian health startups and @Finansavisen has written about it in today's edition. I've snipped out the part about Age Labs.
@Oesch13767736@davidasinclair@NoAge100 I believe we are still fumbling in the dark when it comes to a definitive cause of neurodegenerative brain disease. Do you agree?
I see many empty seats at the Brain Genome Instability Conference @NoAge100. Watch this space. The topic will grow to include effects on #epigenetics and become a major area of scientific interest. https://t.co/9PMdvbsb7U
#brainhealth#aging#longevity
Really excited to make new connections at #undoingaging2019. The event sold out and is absolutely buzzing with people. @ Berlin https://t.co/wOuzUQlEW1